• OPEN AN ACCOUNT
Indian Indices
Nifty
25,149.85 -205.40
(-0.81%)
Sensex
82,500.47 -689.81
( -0.83%)
Bank Nifty
56,754.70 -201.30
( -0.35%)
Nifty IT
37,693.25 -683.40
( -1.78%)
Global Indices
Nasdaq
44,666.69 187.38
(0.42%)
Dow Jones
6,300.60 16.34
(0.26%)
Hang Seng
39,553.98 -92.38
(-0.23%)
Nikkei 225
8,941.12 -34.54
(-0.38%)
Forex
USD-INR
85.73 0.00
(0.00%)
EUR-INR
100.42 -0.13
(-0.13%)
GBP-INR
116.48 -0.10
(-0.08%)
JPY-INR
0.58 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
345.7618998
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
19.53
105090.54
EPS(TTM)
Face Value()
Div & Yield %
64.48
1
0.63
 

Power Grid Corporation of India Ltd
Bharti Airtel partners with Ericsson for rollout of Fixed Wireless Access services in India
Jul 09,2025

Bharti Airtel and Ericsson (NASDAQ: ERIC) have deepened their long-standing relationship with a new agreement to support Bharti Airtel's rollout of Fixed Wireless Access (FWA) services in India with its core network portfolio. The deployment will enhance Airtel core capability and capacity for Fixed Wire less Access, thereby elevating the customer experience for Airtel FWA users.

As part of this agreement, Ericsson is introducing a new platform which will support higher capacity with a smaller footprint and better total cost of ownership. The solution builds on the previously an nounced dual-mode 5G Core solution deal between Ericsson and Airtel for 5G packet core which cre ated a unified and future-ready network infrastructure, underpinning Airtel's journey to 5G Standalone (SA).